Literature DB >> 26705418

Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology.

Connie W Tsao1, Ramachandran S Vasan2.   

Abstract

The Framingham Heart Study (FHS) has conducted seminal research defining cardiovascular disease (CVD) risk factors and fundamentally shaping public health guidelines for CVD prevention over the past five decades. The success of the Original Cohort, initiated in 1948, paved the way for further epidemiological research in preventive cardiology. Due to the keen observations suggesting the role of shared familial factors in the development of CVD, in 1971 the FHS began enroling the second generation cohort, comprising the children of the Original Cohort and the spouses of the children. In 2002, the third generation cohort, comprising the grandchildren of the Original Cohort, was initiated to additionally explore genetic contributions to CVD in greater depth. Additionally, because of the predominance of White individuals of European descent in the three generations of FHS participants noted above, the Heart Study enrolled the OMNI1 and OMNI2 cohorts in 1994 and 2003, respectively, aimed to reflect the current greater racial and ethnic diversity of the town of Framingham. All FHS cohorts have been examined approximately every 2-4 years since the initiation of the study. At these periodic Heart Study examinations, we obtain a medical history and perform a cardiovascular-focused physical examination, 12-lead electrocardiography, blood and urine samples testing and other cardiovascular imaging studies reflecting subclinical disease burden.The FHS has continually evolved along the cutting edge of cardiovascular science and epidemiological research since its inception. Participant studies now additionally include study of cardiovascular imaging, serum and urine biomarkers, genetics/genomics, proteomics, metabolomics and social networks. Numerous ancillary studies have been established, expanding the phenotypes to encompass multiple organ systems including the lungs, brain, bone and fat depots, among others. Whereas the FHS was originally conceived and designed to study the epidemiology of cardiovascular disease, it has evolved over the years with staggering expanded breadth and depth that have far greater implications in the study of the epidemiology of a wide spectrum of human diseases. The FHS welcomes research collaborations using existing or new collection of data. Detailed information regarding the procedures for research application submission and review are available at [http://www.framinghamheartstudy.org/researchers/index.php].
© The Author 2015; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26705418      PMCID: PMC5156338          DOI: 10.1093/ije/dyv337

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  111 in total

1.  The silent coronary: the frequency and clinical characteristics of unrecognized myocardial infarction in the Framingham study.

Authors:  J STOKES; T R DAWBER
Journal:  Ann Intern Med       Date:  1959-06       Impact factor: 25.391

2.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

3.  Parental history is an independent risk factor for coronary artery disease: the Framingham Study.

Authors:  R H Myers; D K Kiely; L A Cupples; W B Kannel
Journal:  Am Heart J       Date:  1990-10       Impact factor: 4.749

4.  Integromic analysis of genetic variation and gene expression identifies networks for cardiovascular disease phenotypes.

Authors:  Chen Yao; Brian H Chen; Roby Joehanes; Burcak Otlu; Xiaoling Zhang; Chunyu Liu; Tianxiao Huan; Oznur Tastan; L Adrienne Cupples; James B Meigs; Caroline S Fox; Jane E Freedman; Paul Courchesne; Christopher J O'Donnell; Peter J Munson; Sunduz Keles; Daniel Levy
Journal:  Circulation       Date:  2014-12-22       Impact factor: 29.690

5.  The association of total cholesterol, triglycerides and plasma lipoprotein cholesterol levels in first degree relatives and spouse pairs.

Authors:  R J Garrison; W P Castelli; M Feinleib; W B Kannel; R J Havlik; S J Padgett; P M McNamara
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

6.  Healthy People 2000. The rationale and potential efficacy of preventive nutrition in heart disease: the Framingham Offspring-Spouse Study.

Authors:  B M Posner; L A Cupples; D Gagnon; P W Wilson; K Chetwynd; D Felix
Journal:  Arch Intern Med       Date:  1993-07-12

7.  The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study.

Authors:  Joanne M Murabito; Jane C Evans; Martin G Larson; Kenneth Nieto; Daniel Levy; Peter W F Wilson
Journal:  Arch Intern Med       Date:  2003-09-08

8.  Cholesterol and mortality. 30 years of follow-up from the Framingham study.

Authors:  K M Anderson; W P Castelli; D Levy
Journal:  JAMA       Date:  1987-04-24       Impact factor: 56.272

9.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

10.  The natural history of borderline isolated systolic hypertension.

Authors:  A Sagie; M G Larson; D Levy
Journal:  N Engl J Med       Date:  1993-12-23       Impact factor: 91.245

View more
  94 in total

1.  Reducing exposure to cardiovascular risk factors: the legacy of prevention.

Authors:  Benoit J Arsenault; Rishi Puri
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Invited Commentary: The Framingham Offspring Study-A Pioneering Investigation Into Familial Aggregation of Cardiovascular Risk.

Authors:  JoAnn E Manson; Shari S Bassuk
Journal:  Am J Epidemiol       Date:  2017-06-01       Impact factor: 4.897

3.  Cigarette Smoke Exposure and Radiographic Pulmonary Vascular Morphology in the Framingham Heart Study.

Authors:  Andrew J Synn; Chunyi Zhang; George R Washko; Raúl San José Estépar; George T O'Connor; Wenyuan Li; Murray A Mittleman; Mary B Rice
Journal:  Ann Am Thorac Soc       Date:  2019-06

4.  Prognosis of Prehypertension Without Progression to Hypertension.

Authors:  Teemu J Niiranen; Martin G Larson; Elizabeth L McCabe; Vanessa Xanthakis; Ramachandran S Vasan; Susan Cheng
Journal:  Circulation       Date:  2017-09-26       Impact factor: 29.690

5.  Healthy diet is associated with gene expression in blood: the Framingham Heart Study.

Authors:  Honghuang Lin; Gail T Rogers; Kathryn L Lunetta; Daniel Levy; Xiao Miao; Lisa M Troy; Paul F Jacques; Joanne M Murabito
Journal:  Am J Clin Nutr       Date:  2019-09-01       Impact factor: 7.045

Review 6.  Genomics and electronic health record systems.

Authors:  Lucila Ohno-Machado; Jihoon Kim; Rodney A Gabriel; Grace M Kuo; Michael A Hogarth
Journal:  Hum Mol Genet       Date:  2018-05-01       Impact factor: 6.150

7.  Stroke Research With Longitudinal Cohort Studies.

Authors:  Hugo J Aparicio
Journal:  Stroke       Date:  2019-04       Impact factor: 7.914

8.  Associations Between Midlife (but Not Late-Life) Elevated Coronary Heart Disease Risk and Lower Cognitive Performance: Results From the Framingham Offspring Study.

Authors:  Nicole M Armstrong; Katherine J Bangen; Rhoda Au; Alden L Gross
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

9.  Modeling a bivariate residential-workplace neighborhood effect when estimating the effect of proximity to fast-food establishments on body mass index.

Authors:  A James O'Malley; Peter James; Todd A MacKenzie; Jinyoung Byun; S V Subramanian; Jason P Block
Journal:  Stat Med       Date:  2018-11-20       Impact factor: 2.373

10.  Association of periodontal disease with atherosclerosis in 70-year-old Japanese older adults.

Authors:  Masahiro Kitamura; Kazunori Ikebe; Kei Kamide; Yasuyuki Gondo; Motozo Yamashita; Masahide Takedachi; Takenori Nozaki; Chiharu Fujihara; Satoru Yamada; Yoichiro Kashiwagi; Koji Miki; Tomoaki Iwayama; Kodai Hatta; Yusuke Mihara; Yuko Kurushima; Hajime Takeshita; Mai Kabayama; Ryousuke Oguro; Tatsuo Kawai; Hiroshi Akasaka; Yasushi Takeya; Koichi Yamamoto; Ken Sugimoto; Tatsuro Ishizaki; Yasumichi Arai; Yukie Masui; Ryutaro Takahashi; Hiromi Rakugi; Yoshinobu Maeda; Shinya Murakami
Journal:  Odontology       Date:  2020-11-04       Impact factor: 2.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.